These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7319468

  • 1. Serum prolactin and oestradiol levels in women with cyclical mastalgia.
    Watt-Boolsen S, Andersen AN, Blichert-Toft M.
    Horm Metab Res; 1981 Dec; 13(12):700-2. PubMed ID: 7319468
    [Abstract] [Full Text] [Related]

  • 2. Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast.
    Watt-Boolsen S, Eskildsen PC, Blaehr H.
    Cancer; 1985 Aug 01; 56(3):500-2. PubMed ID: 4005811
    [Abstract] [Full Text] [Related]

  • 3. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W, Leipert KP, Gehrlings H, Stauch G, von zur Mühlen A, Schneider J.
    Geburtshilfe Frauenheilkd; 1986 May 01; 46(5):284-9. PubMed ID: 3087811
    [Abstract] [Full Text] [Related]

  • 4. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
    Rose DP, Cohen LA, Berke B, Boyar AP.
    J Natl Cancer Inst; 1987 Apr 01; 78(4):627-31. PubMed ID: 3470539
    [Abstract] [Full Text] [Related]

  • 5. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
    Rea N, Bove F, Gentile A, Parmeggiani U.
    Minerva Med; 1997 Nov 01; 88(11):479-87. PubMed ID: 9433398
    [Abstract] [Full Text] [Related]

  • 6. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC, Sellwood RA, Knyba RE, Irvine JD.
    Clin Oncol; 1981 Sep 01; 7(3):213-9. PubMed ID: 6211319
    [No Abstract] [Full Text] [Related]

  • 7. Serum prolactin levels in patients with fibrocystic breast disease.
    Peters F, Schuth W, Scheurich B, Breckwoldt M.
    Obstet Gynecol; 1984 Sep 01; 64(3):381-5. PubMed ID: 6431348
    [Abstract] [Full Text] [Related]

  • 8. Controlled trial of the prolactin inhibitor bromocriptine (Parlodel) in the treatment of severe cyclical mastalgia.
    Nazli K, Syed S, Mahmood MR, Ansari F.
    Br J Clin Pract; 1989 Sep 01; 43(9):322-7. PubMed ID: 2695151
    [Abstract] [Full Text] [Related]

  • 9. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G, Govindarajulu P, Ramalingam V.
    Neoplasma; 1989 Sep 01; 36(2):221-31. PubMed ID: 2497392
    [Abstract] [Full Text] [Related]

  • 10. Serum oestradiol-17 beta and prolactin concentrations during the luteal phase in women with benign breast disease.
    Walsh PV, McDicken IW, Bulbrook RD, Moore JW, Taylor WH, George WD.
    Eur J Cancer Clin Oncol; 1984 Nov 01; 20(11):1345-51. PubMed ID: 6542005
    [Abstract] [Full Text] [Related]

  • 11. Cyclical mastalgia and breast pathology.
    Jørgensen J, Watt-Boolsen S.
    Acta Chir Scand; 1985 Nov 01; 151(4):319-21. PubMed ID: 4041107
    [Abstract] [Full Text] [Related]

  • 12. [Features of breast ultrasound image and its correlation with estradiol and progesterone level in different phases of menstrual cycle in normal women].
    Zhou YZ, Jiang YX, Sun Q, Zhang SQ, Zhang Y, Chen FL, Lin SQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec 01; 23(6):609-13. PubMed ID: 12901108
    [Abstract] [Full Text] [Related]

  • 13. A double-blind randomized controlled trial of toremifen therapy for mastalgia.
    Gong C, Song E, Jia W, Qin L, Guo J, Jia H, Hu X, Su F.
    Arch Surg; 2006 Jan 01; 141(1):43-7. PubMed ID: 16415410
    [Abstract] [Full Text] [Related]

  • 14. A randomised controlled trial of medroxyprogesterone acetate in mastalgia.
    Maddox PR, Harrison BJ, Horobin JM, Walker K, Mansel RE, Preece PE, Nicholson RI.
    Ann R Coll Surg Engl; 1990 Mar 01; 72(2):71-6. PubMed ID: 2139769
    [Abstract] [Full Text] [Related]

  • 15. Cyclical mastalgia and breast cancer risk: results of a French cohort study.
    Plu-Bureau G, Lê MG, Sitruk-Ware R, Thalabard JC.
    Cancer Epidemiol Biomarkers Prev; 2006 Jun 01; 15(6):1229-31. PubMed ID: 16775187
    [Abstract] [Full Text] [Related]

  • 16. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins.
    Rose DP, Boyar AP, Cohen C, Strong LE.
    J Natl Cancer Inst; 1987 Apr 01; 78(4):623-6. PubMed ID: 3104646
    [Abstract] [Full Text] [Related]

  • 17. Correlation between incremental changes of oestradiol-17 beta and prolactin during the menstrual cycle by means of multiple plasma sampling.
    Kicovic PM, Franchi F, Lusi M.
    Reproduccion; 1981 Apr 01; 5(1):43-8. PubMed ID: 7250484
    [Abstract] [Full Text] [Related]

  • 18. Bromocriptine treatment of cyclical mastalgia/fibrocystic breast disease: update on the European trial.
    Dogliotti L, Mansel RE.
    Br J Clin Pract Suppl; 1989 Nov 01; 68():26-32; discussion 49-53. PubMed ID: 2488563
    [No Abstract] [Full Text] [Related]

  • 19. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)].
    Bischoff J, Rebhan EM, Prestele H, Becker H.
    Geburtshilfe Frauenheilkd; 1980 Jan 01; 40(1):65-71. PubMed ID: 7353778
    [Abstract] [Full Text] [Related]

  • 20. Prolactin and breast cancer risk.
    Ingram DM, Nottage EM, Roberts AN.
    Med J Aust; 1990 Oct 15; 153(8):469-73. PubMed ID: 2215338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.